Announcements

Intimation that as the final dividend is subject to approval of members, the provision made therefor has been revised, resulting in increase of Rs.323.30 Million in Reserves & Surplus and decrease of similar amount from Short-term provisions. The revised Audited Financial Statements (both Stand-alone and Consolidated), are provided under Financial Statements.

Intimation about meetings of
Mr. Sudarshan Padmanabhan, Analyst, Sundaram Mutual Fund, with our Vice-President, Dr. Caesar Sengupta, General Manager-Finance, Mr. Sachin Salvi, and Mr. Vatsal Goyal, Head–Nueclear Operations, by 10.00 A.M. on Thursday, June 08, 2017, at our office.
Mr. Thomas Mobille, Director/Senior Analyst, Limiar Capital Management, USA, with our General Manager-Finance, Mr. Sachin Salvi, and Mr. Vatsal Goyal, Head–Nueclear Operations, by 4.00 P.M. on Thursday, June 08, 2017, at our office.

Intimation about Mr. Sachin Salvi, General Manager-Finance and Mr. Vatsal Goyal, Head – Nueclear Operations, participating at an investor conference organized by M/s. Batlivala & Karani Securities India Pvt. Ltd., at Hotel Trident, BKC, on 7th June 2017, where the following fund managers will participate.

Intimation about meeting of the representatives of various funds, as follows, with our Chairman & Managing Director, Dr. A. Velumani, scheduled to take place from 5th to 8th June 2017, during his visit to Hong Kong and Singapore

Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani, in an investor conference on 30th May, 2017 at Hotel Sofitel, BKC, Mumbai, an open session attended by global / domestic institutional investors / fund houses, etc., being arranged by Phillip Capital.

Intimation about conference call on 11-05-2017 about the Audited financial results for the quarter / whole year ended March 31, 2017

Intimation about decisions taken at the Board Meeting held on May 09, 2017, about approval of the Audited Financial Statements (both Stand-alone and Consolidated), Granting of Stock Options to the Employees for the FY 2016-17 and recommending a final dividend of Rs.5/- per share, which is in addition to the interim dividend of Rs. 5/- already paid. With this, the total dividend for the year would be 100%.

Intimation about Board Meeting scheduled to be held on May 09, 2017 to approve audited financial statements (both Stand-alone and Consolidated) for FY 2016-17 and to consider granting of Stock Options to eligible employees for FY 2016-17.

Intimation about meeting of the representatives of various funds, as follows, with our Chairman & Managing Director, Dr. A. Velumani, scheduled to take place on 26th & 27th April 2017 during his visit to UK.

Intimation about meeting of Mr. Mahesh Natarajan of ICICI Securities and Mr. Shriraam Rathi, ISec Healthcare Research Analyst, with our Chairman & Managing Director, Dr. A. Velumani on Monday, April 10, 2017 by 9.30 a.m. at our office.

Intimation about meeting of Analysts from Falcon Edge, Comgest, Goldman Sachs, PineBridge, East Bridge and a few other Investors, with our Chairman & Managing Director, Dr. A. Velumani on Monday, April 10, 2017 by 11.00 a.m., followed by a visit to our central Processing Laboratory at Navi Mumbai.

Intimation about meeting of Mr. Anmol Ganjoo, of J M Financial, with our General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, Turbhe, Navi Mumbai, on Friday, April 07, 2017, by 10.00 A.M.

Intimation about meeting of Mr. Abhishek Thepade, Fund Manager of DNB Nor, with our General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, Turbhe, Navi Mumbai, on Wednesday, March 29, 2017 by 10.00 A.M

Intimation about the following decisions taken at the Board Meeting held on March 24, 2017, subject to approval of Members wherever necessary:
(i) To reappoint Dr. A. Velumani as Managing Director & CEO for 3 years from 01-04-2017 on a token salary of Re. 1/- per month as chosen by him.
(ii) To reappoint Mr. A. Sundararaju as Executive Director & CFO for 3 years from 01-04-2017 on the same salary of Rs. 5 lakhs per month.
(iii) To acquire the trademark “Whaters” from Dr. A. Velumani, Chairman & Managing Director, who offered to assign the same to the Company for a token consideration of Re. 1/- and the trademark “Nueclear” to NHL, the wholly owned subsidiary, for a similar token consideration of Re. 1/-, and also waive the royalty due to him from both the companies for usage till now.
(iv) To give loan to NHL, the wholly owned subsidiary, at arm’s length basis, to help them acquire costly equipment like Cyclotron, PET-CT Scan machines, etc. for setting up additional scanning centres.

Intimation about meeting of Mr. Rahul Gupta, Investment Analyst, of Fidelity International, with our General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, Turbhe, Navi Mumbai, on Thursday, March 23, 2017 by 10.30 A.M.

Intimation about change in timing of Conference Call between Mr. Anubhav Aggarwal, Healthcare Analyst from Credit Suisse and our General Manager- Finance, Mr. Sachin Salvi, on Wednesday, March 08, 2017 as 3.30 P.M., where some other analysts/investors might also join.

Intimation about a Conference Call between Mr. Anubhav Aggarwal, Healthcare Analyst from Credit Suisse and our General Manager- Finance, Mr. Sachin Salvi, on Wednesday, March 08, 2017 by 11.00 A.M.

Intimation about meeting of Mr. Kahlil Randeria and his team from New Horizon Funds, India, with our Chairman & Managing Director, Dr. A. Velumani, by 05.00 P.M. on Wednesday, March 01, 2017, at our Corporate Office.

Intimation about meeting of Mr. Owens Huang, Asia Specialist & Co-Portfolio Manager from Dalton Investment, US, with our Vice-President (Operations), Dr. Caesar Sengupta, and General Manager-Finance, Mr. Sachin Salvi, at our Corporate Office, on Tuesday, February 28, 2017 by 03.00 P.M.

Intimation about meeting of Mr. Anup Maheshwari, CIO & Head of Equities of DSP Blackrock, and his team, with our Chairman & Managing Director, Dr. A. Velumani, at our Corporate Office, on Monday, February 27, 2017 by 12.00 Noon.

Intimation about meeting of Mr. Dushyant Sahani, Associate, of Samena Capital Investments Limited, Dubai, with our Vice President (Operations) Dr. Caesar Sengupta and General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, on Tuesday, February 21, 2017 by 03.00 PM and a likely meeting with our Chairman & Managing Director, Dr. A. Velumani too, subject to his availability.

Intimation about meeting of Mr. Atul Mehra, Senior Analyst, and Mr. Prateek, of Motilal Oswal Mutual Fund, with our General Manager-Finance, Mr.Sachin Salvi and the Marketing Team at our Corporate Office, on Wednesday, February 15, 2017 by 11.00 AM, and a likely visit to one of our franchisees thereafter.

Intimation about meeting of Mr. Balvinder Singh, Analyst from Canara HSBC, with our Vice-President (Operations), Dr. Caesar Sengupta and General Manager-Finance, Mr. Sachin Salvi, at our office by 5.00 PM on 09-02-2017.

Intimation about conference call on 31-01-2017 about the unaudited financial results for the quarter / nine-months ended December 31, 2016.

Intimation of Outcome of the Board Meeting held on January 28, 2017 .(i) To declare an interim dividend of Rs. 5/- per share and fixing of 09-02-2017 as record date for payment of dividend and (ii) To approve the unaudited financial results (Stand alone and Consolidated) for the quarter / nine months ended December 31, 2016.

Intimation about meeting of Mr. Jack and Mr. Mohan of Stewart Investors, UK, with our Chairman & Managing Director, Dr. A. Velumani at our office by 3.00 PM on 08-02-2017.

Intimation about Board Meeting scheduled to be held on January 28, 2017 to approve unaudited financial statements (both Stand-alone and Consolidated) for the quarter/nine months ended 31-12-2016, and consider paying interim dividend if any.

Intimation about meeting of our General Manager-Finance, Mr. Sachin Salvi, with Mr.Shaleen Kumar of UBS Securities India, at our office by 10.00 A.M. on 26-12-2016.

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Ms. Amisha Vora & Mr. Dilip Bhat, Joint Managing Directors, and Mr. Vishal & Mr. Shankar, Co-Heads-Equities, of Prabhudas Lilladher Pvt. Ltd. at our office by 3.00 P.M. on 22-12-2016.

Intimation about meeting of our Chairman & Managing Director, Dr. A. Velumani with Mr. Sandeep Kothari and Mr. Rahul Gupta, of Fidelity International at our office by 9.00 A.M. on 23-12-2016

Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani, in Spark Healthcare Conference 2016, in BKC, Mumbai on 13-12-2016.